MichBio

Could new federal biotechnology legislation reshape how life sciences companies structure partnerships and licensing agreements?

The proposed Biotechnology Innovation and National Security Act (BINSA) could expand government review of certain biotechnology transactions involving covered foreign entities.

For biotech companies, the implications may extend well beyond manufacturing and supply chains—potentially affecting licensing, collaborations, and investment decisions.

Read more: https://ow.ly/wHFN50Zbiub

What questions does your organization have about BINSA?

Looking for non-dilutive funding opportunities?

The June Government Bioscience Grants (GBG) Report by G2G - Innovative Government Affairs Consulting includes 129 funding opportunities, forecasts, notices of special interest, requests for information, and other funding resources relevant to life sciences organizations.

Whether you're a startup, researcher, entrepreneur, or established company, identifying the right funding opportunity can be a game changer.

What's your biggest challenge when pursuing government funding?

Access the June report and webinar details: https://www.michbio.org/news/june-2026-gbg-report-available